Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health
Name
Revised Manuscript-Final Cleancopy.pdf
Description
Accepted version
Size
276.65 KB
Format
Adobe PDF
Checksum (MD5)
ff42b9785295d3a3a1be0b277ae3c637
Author(s)
O'Day, Elizabeth
Hosta-Rigau, Leticia
Oyarzún, Diego A.
Okano, Hideyuki
de Lorenzo, Víctor
von Kameke, Conrad
Alsafar, Habiba
Cao, Cong
Chen, Guo-Qiang
Ji, Weizhi
Date Issued
May 2018
Journal
Biotechology Journal
Publisher
Wiley
Citation
O'Day, Elizabeth et al. "Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health." Biotechology Journal 14, 1 (January 2019): 1800195 © 2018 WILEY-VCH Verlag GmbH & Co.
Version
Author's final manuscript
Abstract
Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-rays reveal a fractured hip, which will require total hip replacement surgery.
MIT Department
McGovern Institute for Brain Research at MIT
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1002/biot.201800195
